Clinical Trial Update: Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating Cytochlor and tetrahydrouridine with external-beam radiation therapy for brain and central nervous system tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Neoplasms

Drugs mentioned

• Cytochlor (chlorambucil)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: Brian Lally | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED